Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays-Reference-Cited by-同舟云学术

Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays

Published:2008-01 Issue:1 Volume:10 Page:50-57
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Jhavar Sameer,Reid Alison,Clark Jeremy,Kote-Jarai Zsofia,Christmas Timothy,Thompson Alan,Woodhouse Christopher,Ogden Christopher,Fisher Cyril,Corbishley Cathy,De-Bono Johann,Eeles Rosalind,Brewer Daniel,Cooper Colin

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference21 articles.

1. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming;Iljin;Cancer Res,2006

2. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer;Hermans;Cancer Res,2006

3. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer;Tomlins;Cancer Res,2006

4. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer;Tomlins;Science,2005

5. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer;Wang;Cancer Res,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of tmprss2-erg and tmprss2-egr1 gene fusion in prostate cancer from a Chinese population;Egyptian Journal of Medical Human Genetics;2020-12

2. Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms;Nature Communications;2019-07-15

3. DESNT: A Poor Prognosis Category of Human Prostate Cancer;European Urology Focus;2018-12

4. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer;Oncotarget;2017-03-18

5. THSD7A expression in human cancer;Genes, Chromosomes and Cancer;2017-02-06